ScholarIQanswers from OpenAlex

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective

PaperCitations, authors & open-access status

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective have?

ScholarIQcitation count

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective has 118 citations in the OpenAlex counts ScholarIQ stores.

When was Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective published?

ScholarIQyear

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective has 2022 year in the ScholarIQ index.

What is the open-access status of Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective?

ScholarIQoa status

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective has hybrid oa status in the ScholarIQ index.

What is the DOI of Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective?

ScholarIQdoi

The DOI for Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective is on the source record.

What is the PMID of Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective?

ScholarIQpmid

The PMID for Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective is on the source record.

What is the OpenAlex record for Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective?

ScholarIQopenalex

The OpenAlex for Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial